These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22364715)

  • 21. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
    Shah SM; Barron A; Klinger C; Wright JS
    Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".
    Henshall C; Schuller T; Mardhani-Bayne L
    Int J Technol Assess Health Care; 2012 Jul; 28(3):203-10. PubMed ID: 22792877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
    Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
    Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the performance of health technology assessment organizations: a framework.
    Lafortune L; Farand L; Mondou I; Sicotte C; Battista R
    Int J Technol Assess Health Care; 2008; 24(1):76-86. PubMed ID: 18218172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Innovation in health care: the role of HTA in the introduction of new technologies].
    Bührlen B
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of health technology assessment in Lithuania.
    Danguole J
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():140-2. PubMed ID: 19575824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health technology assessment development in China.
    Chen Y; Banta D; Tang Z
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():202-9. PubMed ID: 19575825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of health technology assessment in decision making: coresponsibility of users and producers?
    Hivon M; Lehoux P; Denis JL; Tailliez S
    Int J Technol Assess Health Care; 2005; 21(2):268-75. PubMed ID: 15921069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FRAMEWORK FOR USER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT THE LOCAL LEVEL: VIEWS OF HEALTH MANAGERS, USER REPRESENTATIVES, AND CLINICIANS.
    Gagnon MP; Desmartis M; Gagnon J; St-Pierre M; Rhainds M; Coulombe M; Tantchou MD; Légaré F
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):68-77. PubMed ID: 25952585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAKEHOLDER INVOLVEMENT THROUGHOUT HEALTH TECHNOLOGY ASSESSMENT: AN EXAMPLE FROM PALLIATIVE CARE.
    Brereton L; Wahlster P; Mozygemba K; Lysdahl KB; Burns J; Polus S; Tummers M; Refolo P; Sacchini D; Leppert W; Chilcott J; Ingleton C; Gardiner C; Goyder E
    Int J Technol Assess Health Care; 2017 Jan; 33(5):552-561. PubMed ID: 28868993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany.
    Kieslich K
    Health Econ Policy Law; 2020 Jul; 15(3):370-385. PubMed ID: 30975237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing Health Technology Assessment to address health care system needs.
    Velasco Garrido M; Gerhardus A; Røttingen JA; Busse R
    Health Policy; 2010 Mar; 94(3):196-202. PubMed ID: 19889471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating local data into hospital-based healthcare technology assessment: two case studies.
    Mitchell MD; Williams K; Brennan PJ; Umscheid CA
    Int J Technol Assess Health Care; 2010 Jul; 26(3):294-300. PubMed ID: 20584358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.